Login / Signup

Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy.

Yi MaZaiwei SongXinya LiDan JiangRongsheng ZhaoZhan-Miao Yi
Published in: Clinical pharmacokinetics (2024)
PROSPERO registration number CRD42022347907.
Keyphrases
  • venous thromboembolism
  • atrial fibrillation
  • pulmonary embolism
  • genome wide
  • copy number
  • stem cells
  • gene expression
  • bone marrow